Wockhardt to boost innovative drug R&D capabilities

摘要

Wockhardt will continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines. Addressing the shareholders in the company's annual report, Wockhardt Managing Director Mr. Murtaza Khorakiwala said the firm has set up three world-class, multi-disciplinary R&D facilities in India, the UK and the US, which are engaged in studies and experiments to develop new drugs and novel drug delivery systems for tomorrow.